Clover Health Investments, Corp (CLOV) Stock Price & How to Invest
Last updated July 2026
Short answer
You can invest in Clover Health (CLOV) by buying shares or fractional shares at any major US broker, through a healthcare or small-cap ETF that holds it, or as one holding in a thematic basket. Clover Health is a healthcare-technology company that runs Medicare Advantage plans for US seniors, mostly through wide-network PPO plans, and pairs them with its proprietary software platform, Clover Assistant, which analyzes patient data to help physicians catch conditions early and manage care. The core thesis is that its technology-first, physician-enablement model can grow membership faster than legacy insurers while improving medical costs. The single biggest thing to understand is that this is a still-maturing insurer that only recently reached profitability, so the story rests on sustaining membership growth and disciplined medical-cost management, both of which can swing results sharply.
CLOV stock price
As of 2026-07-14, Clover Health Investments, Corp (CLOV) last closed at $4.77, up 59.0% over the past year. Over the past 52 weeks it has traded between $1.70 and $5.41.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Clover Health Investments, Corp's investor relations page. Walnut is informational, not investment advice.
What does Clover Health Investments, Corp (CLOV) do?
Clover Health Investments, Corp. is a US healthcare-technology company that offers Medicare Advantage plans, the private alternative to traditional Medicare, primarily to seniors. Unlike many rivals that lean on narrow-network HMO plans, Clover concentrates on wide-network PPO plans that let members see a broad range of doctors, which the company argues is a differentiator for seniors who value choice. At the heart of the business is Clover Assistant, a proprietary software platform that pulls together patient data and surfaces insights to physicians at the point of care, aiming to catch chronic conditions earlier and manage costs more effectively than a traditional insurer.
After years of losses common to fast-growing insurtechs, Clover's recent narrative is a turn toward profitability. The company reported strong Medicare Advantage membership growth into the 2026 plan year, with membership up roughly 50% year over year to around 150,000-plus members, and it guided to full-year 2026 revenues in the multi-billion-dollar range with positive adjusted EBITDA and its first year of GAAP net income profitability. A favorable revision of its 2026 CMS Star Rating for its main PPO contract (raised to 4.5 stars after a court order, covering the large majority of members) is a meaningful tailwind because higher Star Ratings drive bonus payments and rebates. The investment picture combines rapid membership growth and improving economics against the backdrop of a heavily regulated, competitive market dominated by much larger insurers.
What's driving Clover Health Investments, Corp (CLOV)?
1. Medicare Advantage membership growth
Clover has been growing membership far faster than the broader Medicare Advantage market, with roughly 50% year-over-year growth into the 2026 plan year and guidance for continued expansion. Rapid membership gains drive revenue and can spread fixed technology and administrative costs across a larger base. Sustaining that growth at healthy unit economics, rather than buying membership at a loss, is the central question.
2. Path to profitability
After years of losses, Clover guided to positive adjusted EBITDA and its first full year of GAAP net income profitability in 2026, and reported positive results early in the year. Reaching sustained profitability would validate the model and reduce reliance on external capital. The durability of that shift depends on keeping the medical-cost ratio in check as the membership base grows and ages.
3. Clover Assistant and technology model
Clover Assistant, the company's proprietary physician-facing software, is the differentiator management points to for earlier condition detection and better cost management. If the platform genuinely improves medical outcomes and costs at scale, it can support both growth and margins in a way legacy insurers struggle to match. The payoff hinges on the technology delivering measurable cost advantages across a much larger member base.
4. Star Ratings and PPO positioning
A higher 2026 CMS Star Rating (raised to 4.5 stars on its main PPO contract covering most members) improves bonus payments and rebates that fund richer benefits and growth. Clover's wide-network PPO focus differentiates it from narrow-network rivals for choice-seeking seniors. Star Ratings are set by CMS and can move year to year, so this tailwind must be defended annually rather than assumed.
What are the risks to Clover Health Investments, Corp (CLOV)?
The dominant risk is that Clover is a small insurer competing against giants like UnitedHealth, Humana, CVS/Aetna, and Centene, which have far greater scale, capital, and provider leverage. Medicare Advantage economics are highly sensitive to the medical-cost ratio: if members use more care than priced, a fast-growing book can swing back to losses quickly. The business is heavily dependent on CMS policy, reimbursement rates, risk-adjustment rules, and Star Ratings, all of which are outside the company's control and can change materially between plan years. Profitability is recent and not yet long-proven, so the turn could reverse if growth outpaces cost discipline. Insurtech peers such as Alignment Healthcare, Oscar Health, and Devoted Health add competitive pressure, and the stock has historically been volatile with elevated retail and short-interest attention.
How is Clover Health Investments, Corp (CLOV) valued? (approximate, Jul 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Clover Health Investments, Corp's investor relations page or your broker.
- Medicare Advantage membership: ~150,000-plus members, up roughly 50% year over year into the 2026 plan year (approximate; verify live)
- 2026 revenue guidance: Guided to the multi-billion-dollar range (roughly $2.8B to $2.9B midpoint framing; approximate)
- Profitability: Guided to positive adjusted EBITDA and first full-year GAAP net income profitability in 2026
- 2026 CMS Star Rating: Main PPO contract raised to 4.5 stars (after a court order), covering the large majority of members
- Business model: Wide-network PPO Medicare Advantage plans plus the Clover Assistant software platform
- Valuation framing: Small-cap insurer; check current price, market cap, and how the market prices its growth-versus-profit turn on a live source
All figures here are approximate and tied to the asOf date; verify live numbers before acting. For a fast-growing insurer, the medical-cost ratio (medical claims as a share of premiums), membership growth, and Star Ratings matter more than any single headline number, because small changes in medical costs can swing profitability sharply. Guidance and Star Ratings can be revised, so confirm the latest quarter and CMS status directly rather than relying on these approximations.
Who competes with Clover Health Investments, Corp (CLOV)?
Large national Medicare Advantage insurers
UnitedHealth (UnitedHealthcare), Humana, CVS Health (Aetna), Centene, Cigna, and Elevance Health dominate the Medicare Advantage market with tens of millions of members combined and far greater scale, capital, and provider leverage. They are Clover's largest competitors and set much of the pricing and benefit backdrop that a small insurer must compete against.
Technology-first insurtech peers
Alignment Healthcare, Oscar Health, and Devoted Health are smaller, technology-driven insurers pursuing similar data-and-platform strategies. Alignment in particular emphasizes a high-touch clinical model and its own care platform and has outpaced Clover on growth in some markets. These peers are the most direct comparisons for Clover's insurtech thesis.
Regional plans and traditional Medicare
Regional and nonprofit plans, including Blue Cross Blue Shield affiliates and provider-sponsored Medicare Advantage plans, compete locally for the same seniors. Traditional fee-for-service Medicare with supplemental coverage is also an alternative that seniors can choose instead of any Medicare Advantage plan, shaping overall demand for Clover's product.
How to invest in Clover Health Investments, Corp (CLOV)
There are three common ways to get CLOV exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so CLOV sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where CLOV fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
The bottom line on Clover Health Investments, Corp (CLOV)
Clover Health is a bet on a small, technology-driven Medicare Advantage insurer scaling its PPO membership and Clover Assistant platform toward durable profitability. It rewards continued fast growth and controlled medical costs, and it is exposed to CMS policy, Star Ratings, medical-cost inflation, and competition from far larger insurers.
Build a basket around CLOV with Walnut
Use Clover Health Investments, Corp as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Is CLOV a good stock to buy right now?
+
That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is fast Medicare Advantage membership growth, a recent turn to profitability, a favorable 2026 Star Rating, and the Clover Assistant technology differentiator. The bear case is that Clover is a small insurer competing against giants, its profitability is new and unproven over time, and results are highly sensitive to medical costs and CMS policy. Weigh both against your own portfolio.
What does Clover Health actually do?
+
Clover Health is a healthcare-technology company that sells Medicare Advantage plans, mostly wide-network PPO plans, to US seniors. It pairs those plans with Clover Assistant, a proprietary software platform that gives physicians data-driven insights at the point of care to catch conditions earlier and manage costs. Its revenue comes primarily from the premiums CMS pays for its Medicare Advantage members.
Is Clover Health profitable?
+
Clover spent years unprofitable, as many fast-growing insurtechs do, but it guided to positive adjusted EBITDA and its first full year of GAAP net income profitability in 2026 and reported positive results early in the year. That turn is recent and not yet proven over multiple years, so profitability could still be pressured if medical costs rise faster than expected. Check the latest quarter for current status.
What is Clover Assistant?
+
Clover Assistant is Clover Health's proprietary software platform for physicians. It pulls together a patient's data and surfaces insights and prompts at the point of care, aiming to help doctors identify chronic conditions earlier and manage care more cost-effectively. Management presents it as the key differentiator that separates Clover's model from a traditional insurer, though its long-run cost advantage is still being proven at scale.
Why does Clover focus on PPO plans?
+
Many Medicare Advantage insurers rely on narrow-network HMO plans, but Clover concentrates on wide-network PPO plans that let members see a broad range of doctors without tight network restrictions. Clover argues this choice appeals to seniors who value flexibility, and it has helped drive membership growth. The trade-off is that wide networks can be harder to manage for cost, making the technology platform central to the model.
How do Medicare Star Ratings affect Clover Health?
+
CMS assigns Star Ratings that influence bonus payments and rebates, which insurers use to fund richer benefits and growth. Higher ratings are a meaningful financial tailwind. Clover's 2026 rating on its main PPO contract was raised to 4.5 stars (after a court order), covering the large majority of its members. Because CMS sets ratings and they can change year to year, this benefit must be defended annually.
Who are Clover Health's main competitors?
+
Clover competes against large national Medicare Advantage insurers like UnitedHealth, Humana, CVS/Aetna, Centene, Cigna, and Elevance Health, which dwarf it in scale. It also competes with technology-first insurtech peers such as Alignment Healthcare, Oscar Health, and Devoted Health, and with regional and nonprofit plans, as well as traditional Medicare with supplemental coverage as an alternative for seniors.
Does Clover Health pay a dividend?
+
No. As a small, growth-focused company that only recently reached profitability, Clover Health reinvests in its business rather than paying a dividend. Income is not a reason investors hold the stock. Capital policies can change over time, so check the company's latest investor disclosures before assuming anything about a payout.
Why is CLOV stock so volatile?
+
Clover is a small-cap insurer whose profitability is recent and highly sensitive to medical costs, membership growth, and CMS policy, so results and sentiment can swing sharply. It also drew heavy retail and short-interest attention as a former meme stock, which has amplified price moves. Small changes in the medical-cost ratio or Star Ratings can meaningfully change the outlook, adding to the volatility.
What are the main risks of investing in CLOV?
+
The main risks are competing at small scale against much larger insurers, sensitivity of profits to the medical-cost ratio (a fast-growing book can swing to losses if members use more care than priced), and heavy dependence on CMS policy, reimbursement, and Star Ratings that are outside the company's control. Its recent profitability is not yet proven over time, and the stock has been notably volatile. Insurtech peers add further competitive pressure.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Clover Health Investments, Corp's investor relations page or your broker before making investment decisions.